Humatica advises the Riverside Company on their recent investment in Alter Pharma

ndetails

Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica Advisor to Riverside for AlterPharma

Related News

Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors
10 Juli, 2025 By Humatica

Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors

Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased…

Read more arrowicon
GloCoach & Humatica partner to deliver the most powerful AI-enabled solution to improve organizational effectiveness
09 Juli, 2025 By Humatica

GloCoach & Humatica partner to deliver the most powerful AI-enabled solution to improve organizational effectiveness

Accelerating behavioral change to improve business performance GloCoach, the global leader in AI-enabled leadership development and coaching, and Humatica, the leading advisor in organizational effectiveness…

Read more arrowicon
Humatica Wins RealDeals Private Equity Award for Value Creation Adviser of the Year for a Second Time since 2023
14 Apr., 2025 By Humatica

Humatica Wins RealDeals Private Equity Award for Value Creation Adviser of the Year for a Second Time since 2023

Humatica, the leading specialist advisor to private equity firms on organizational effectiveness, is proud to announce that it has been named Value Creation Adviser of…

Read more arrowicon